Premarket Mover: Palisade Bio Inc (PALI) Down 20.14%

Palisade Bio Inc (PALI) is down Thursday morning, with the stock declining -20.14% in pre-market trading to 1.15. PALI's short-term technical score of 76 indicates that the stock has traded more bullishly over the last month than 76% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, the stock ranks higher than 87% of stocks. Palisade Bio Inc has fallen 26.90% over the past month, closing at $0.69 on August 10. During this period of time, the stock fell as low as $0.58 and as high as $0.75. PALI has an average analyst recommendation of Buy. The company has an average price target of $33.00.

PALI has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on PALI!

See Full PALI Report

Palisade Bio Inc has a Long-Term Technical rank of 12. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 88% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, PALI ranks better than 131% of stocks.

Important Dates for Investors in PALI:

-Palisade Bio Inc is set to release earnings on 2023-11-09. Over the last 12 months, the company has reported EPS of $-17.48. -We do not have a set dividend date for Palisade Bio Inc at this time. Click Here To Get The Full Report on Palisade Bio Inc (PALI)